- Home
- DTSS vs NEPH Comparison
DTSS vs NEPH Comparison
Compare DTSS & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTSS
- NEPH
- Stock Information
- Founded
- DTSS 2014
- NEPH 1997
- Country
- DTSS China
- NEPH United States
- Employees
- DTSS N/A
- NEPH N/A
- Industry
- DTSS Computer Software: Prepackaged Software
- NEPH Medical/Dental Instruments
- Sector
- DTSS Technology
- NEPH Health Care
- Exchange
- DTSS Nasdaq
- NEPH Nasdaq
- Market Cap
- DTSS 14.2M
- NEPH 16.8M
- IPO Year
- DTSS N/A
- NEPH 2004
- Fundamental
- Price
- DTSS $2.13
- NEPH $2.01
- Analyst Decision
- DTSS
- NEPH Buy
- Analyst Count
- DTSS 0
- NEPH 1
- Target Price
- DTSS N/A
- NEPH $5.00
- AVG Volume (30 Days)
- DTSS 53.5K
- NEPH 11.3K
- Earning Date
- DTSS 05-12-2025
- NEPH 05-08-2025
- Dividend Yield
- DTSS N/A
- NEPH N/A
- EPS Growth
- DTSS N/A
- NEPH N/A
- EPS
- DTSS N/A
- NEPH 0.01
- Revenue
- DTSS $47,284,153.00
- NEPH $14,162,000.00
- Revenue This Year
- DTSS N/A
- NEPH $9.23
- Revenue Next Year
- DTSS N/A
- NEPH $12.99
- P/E Ratio
- DTSS N/A
- NEPH $285.92
- Revenue Growth
- DTSS 117.51
- NEPH N/A
- 52 Week Low
- DTSS $1.63
- NEPH $1.36
- 52 Week High
- DTSS $8.56
- NEPH $2.55
- Technical
- Relative Strength Index (RSI)
- DTSS 55.94
- NEPH 59.37
- Support Level
- DTSS $1.84
- NEPH $1.86
- Resistance Level
- DTSS $2.27
- NEPH $2.05
- Average True Range (ATR)
- DTSS 0.15
- NEPH 0.10
- MACD
- DTSS 0.03
- NEPH -0.01
- Stochastic Oscillator
- DTSS 78.13
- NEPH 87.02
About DTSS Datasea Inc.
Datasea Inc is a technology company. Its offers provides acoustic business services (focusing on high-tech acoustic technologies and applications such as ultrasound, infrasound, and Schumann resonance), 5G application services (5G AI multimodal digital business), and other products and services to various corporate and individual customers. The business activity of the group functions through China.
About NEPH Nephros Inc.
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease.